Cutting Edge: A Major Fraction of Human Bone Marrow Lymphocytes Are Th2-Like CD1d-Reactive T Cells That Can Suppress Mixed Lymphocyte Responses
Mark A. Exley(Brigham and Women's Hospital), Steven P. Balk(Beth Israel Deaconess Medical Center), David Avigan(Beth Israel Deaconess Medical Center), Angela Shaulov(Beth Israel Deaconess Medical Center), Syed Muhammad Tahir(Beth Israel Deaconess Medical Center), Olivia Cheng(Beth Israel Deaconess Medical Center), Robert Sackstein(Florida International University), Robin Joyce(Beth Israel Deaconess Medical Center)
Cited by 151
Related Papers
Mutation of the Androgen-Receptor Gene in Metastatic Androgen-Independent Prostate Cancer
|New England Journal of Medicine|1995|1.3k
Randomized Controlled Trial of Yttrium-90–Labeled Ibritumomab Tiuxetan Radioimmunotherapy Versus Rituximab Immunotherapy for Patients With Relapsed or Refractory Low-Grade, Follicular, or Transformed B-Cell Non-Hodgkin’s Lymphoma
|Journal of Clinical Oncology|2002|1.2k
Interleukin-2 and Regulatory T Cells in Graft-versus-Host Disease
|New England Journal of Medicine|2011|1.1k